A single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV infection for as long as a year. Elri Voigt reports on this and some of the other exciting research on long-acting anti-HIV medicines presented at the Conference on Retroviruses and Opportunistic Infections.
“Driving a fast car”; “getting the top three letters”; or “playing the lotto” – nearly 40 years from when HIV was first described, the virus is still a thing of euphemism and stigma. It’s also still infecting at least 4 000 people a day around the world, most of them young people, especially girls and young women. Ufrieda Ho reports.
The ongoing stockouts of contraceptives grossly violate individuals’ and couples’ reproductive rights but alternative measures have not been put in place. If the issues of access to contraceptives are not dealt with, the country will face a baby boom and a rise in HIV infections at the end of the current pandemic writes Thuthukile Mbatha and Annah Maluleke.
Strict COVID-19 measures have had a negative impact on a programme aimed at providing HIV prevention medicine and gender based violence counselling services for vulnerable girls and young women. Adele Baleta reports.
